Firefly NeuroscienceAIFF +4.76%9 Days Payable is 462.47 as of Mar. 2026, which is 60% below its 10-year median of 1,161.46. GuruFocus rates AIFF with a GF Score™ of 9/100. The stock has 4 warning signs investors should review. Among 2,601 Software companies, Firefly Neuroscience ranks better than 94.23% on this metric.
The historical rank and industry rank for Firefly Neuroscience's Days Payable or its related term are showing as below:
AIFF'
s Days Payable Range Over the Past 10 Years
Min: 684.43 Med: 1161.46 Max: 1161.46
Current: 684.43
During the past 5 years, Firefly Neuroscience's highest Days Payable was 1161.46. The lowest was 684.43. And the median was 1161.46.
AIFF's Days Payable is ranked better than 94.23% of 2601
companies
in the Software industry
Industry Median: 54.04
vs AIFF: 684.43
Firefly Neuroscience's Days Payable
increased
from Mar. 2025 (0.00) to Mar. 2026 (462.47).
It may suggest that Firefly Neurosciencedelayed paying its suppliers.
Firefly Neuroscience Days Payable Related Terms
Firefly Neuroscience Days Payable Historical Data
* Premium members only.
The historical data trend for Firefly Neuroscience's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Software - Application subindustry, Firefly Neuroscience's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Firefly Neuroscience Days Payable vs Software Industry
For the Software industry and Technology sector, Firefly Neuroscience's Days Payable distribution charts can be found below:
* The bar in red indicates where Firefly Neuroscience's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Firefly Neuroscience's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Firefly Neuroscience (AIFF) has a Days Payable of 462.47 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Firefly Neuroscience and its competitors. This is 60% below median its historical median of 1,161.46. Over the past decade, Firefly Neuroscience's Days Payable has ranged from 684.43 to 1,161.46. According to the industry distribution chart, Firefly Neuroscience ranks #150 out of 2601 companies in the Software industry, placing it in the top 5.8%.
Is Firefly Neuroscience's Days Payable too high?
Firefly Neuroscience's current Days Payable of 462.47 is 60% below median its 10-year median of 1,161.46. Over the past 10 years, this metric has ranged from a low of 684.43 to a high of 1,161.46. The Software industry median Days Payable is 54.04. Firefly Neuroscience's value of 462.47 is 755.8% above this industry median. Based on the distribution chart, Firefly Neuroscience ranks #150 out of 2601 companies in the Software industry, which is in the top quartile — a strong position relative to peers. Overall, Firefly Neuroscience has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Firefly Neuroscience's Days Payable compare to CXAI and FALC?
According to the Software industry distribution chart, Firefly Neuroscience ranks #150 out of 2601 companies for Days Payable. This places Firefly Neuroscience in the top 6% of its industry — outperforming the majority of peers. The industry median Days Payable is 54.04. Firefly Neuroscience's value of 462.47 is 755.8% above this benchmark. Historically, Firefly Neuroscience's own Days Payable has ranged from 684.43 to 1,161.46 over the past decade. While the company's 10-year median is 1,161.46 vs. the industry median of 54.04, Firefly Neuroscience has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Software company?
The median Days Payable among Software companies is 54.04, based on 2,601 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Firefly Neuroscience's current Days Payable of 462.47 is 755.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Firefly Neuroscience and its competitors. For the Software industry, the median Days Payable is 54.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Firefly Neuroscience's current Days Payable is 462.47, which is 60% below median its own 10-year median of 1,161.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Firefly Neuroscience stock overvalued right now?
Firefly Neuroscience (AIFF) has a current Days Payable of 462.47. The current Days Payable is 462.47, which is 60% below median its 10-year median of 1,161.46 and 755.8% above the Software industry median of 54.04. Firefly Neuroscience's overall GF Score™ is 9/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Firefly Neuroscience (AIFF), the current Days Payable is 462.47 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Firefly Neuroscience Inc is an artificial intelligence company advancing precision neuroscience, applying AI and large-scale electrophysiological data to give clinicians a more complete, objective picture of how an individual patient's brain is functioning. The firm is developing neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support outcomes for people suffering from mental illnesses and cognitive disorders. The company has one reportable segment: the BNA platform. The Company derives revenue from North America.
9GF Score
Get the complete analysis for AIFF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AIFF has been successfully added to your 
